SCHEMBL9480342

SCHEMBL9480342

N#Cc1cnccc1OC(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
ALDH1A1 P00352 1/20 0.46
KMT2A Q03164 5/20 0.45
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
METAP2 P50579 1/20 0.43
METAP1 P53582 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
POLB P06746 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 1/20 0.40
JAK2 O60674 1/20 0.40
USP2 O75604 1/20 0.40
ESR1 P03372 1/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567956 0.81 KMT2A (0.58) LMNAKMT2AMAPTSMN1; SMN2METAP2
SCHEMBL28488504 0.78 KMT2A (0.48) LMNAALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL9099922 0.77 KMT2A (0.43) LMNAALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL9694189 0.77 KMT2A (0.50) LMNAALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL6976790 0.75 KMT2A (0.51) LMNAALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL11443998 0.75 SLC6A3 (0.60) LMNAALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL27544390 0.74 POLB (0.55) LMNAALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL8917839 0.73 SMN1; SMN2 (0.47) KMT2AMAPTSMN1; SMN2SLC6A3HSD17B10
SCHEMBL27821892 0.72 MAPT (0.69) LMNAALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL28794462 0.72 ESR1 (0.61) LMNAKMT2AMAPTSMN1; SMN2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0247381-B1 5-FLUROROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-08-04 EP disclosed
US-5047521-A Anticarcinogenic agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 US disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed